Evaluation of the molecular mechanisms of a palladium(II) saccharinate complex with terpyridine as an anticancer agent

Anti-Cancer Drugs

Volumn 25, Issue 1, 2014, Pages 17-29

  Kacar, Omer ^a   Adiguzel, Zelal ^a   Yilmaz, Veysel T ^b   Cetin, Yuksel ^a   Cevatemre, Buse ^c   Arda, Nazli ^e   Baykal, Ahmet T ^a   Ulukaya, Engin ^d   Acilan, Ceyda ^a  

^a MATERIALS INSTITUTE   (Turkey)

^b Department of Chemistry ^*  (Turkey)

^c Faculty of Arts and Sciences   (Canada)

^d ULUDAG UNIVERSITY   (Turkey)

^e ISTANBUL UNIVERSITY   (Turkey)

Author keywords

Apoptosis; Cancer; Cytotoxicity; Metal based anticancer agents; Palladium(II) complex

Indexed keywords

ANTINEOPLASTIC METAL COMPLEX; CASPASE 3; CASPASE 7; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; PALLADIUM SACCHARINATE COMPLEX; PROTEIN BAX; PROTEIN P53; UNCLASSIFIED DRUG;

AMPLICON; ANIMAL CELL; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL DEATH; CELL STRESS; CELL VIABILITY; CHO CELL; CONTROLLED STUDY; CYTOTOXICITY; DNA FRAGMENTATION; DOUBLE STRANDED DNA BREAK; DRUG DNA INTERACTION; DRUG SCREENING; ENZYME ACTIVITY; FEMALE; GLIOBLASTOMA; HELA CELL; HUMAN; HUMAN CELL; IC 50; IN VITRO STUDY; MALE; MOLECULAR DYNAMICS; NEUROBLASTOMA CELL; NONHUMAN; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN FUNCTION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SMOOTH MUSCLE FIBER; STRUCTURE ACTIVITY RELATION;

ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL LINE, TUMOR; COORDINATION COMPLEXES; DNA BREAKS, DOUBLE-STRANDED; HUMANS; PALLADIUM;

EID: 84889244305     PISSN: 09594973     EISSN: 14735741     Source Type: Journal    
DOI: 10.1097/CAD.0b013e328364c6ad     Document Type: Article

References (33)

1. Zhang J, Wang L, Xing Z, Liu D, Sun J, Li X, et al. Status of bi- and multinuclear platinum anticancer drug development. Anticancer Agents Med Chem 2010; 10:272-282.
2. Lebwohl D, Canetta R. Clinical development of platinum complexes in cancer therapy: an historical perspective and an update. Eur J Cancer 1998; 34:1522-1534. (Pubitemid 28446332)
3. Shah N, Dizon DS. New-generation platinum agents for solid tumors. Future Oncol 2009; 5:33-42.
4. Olszewski U, Hamilton G. A better platinum-based anticancer drug yet to come? Anticancer Agents Med Chem 2010; 10:293-301.
5. Rixe O, Ortuzar W, Alvarez M, Parker R, Reed E, Paull K, et al. Oxaliplatin, tetraplatin, cisplatin, and carboplatin: spectrum of activity in drug-resistant cell lines and in the cell lines of the national cancer institute's anticancer drug screen panel. Biochem Pharmacol 1996; 52:1855-1865. (Pubitemid 26419675)
6. Abu-Surrah AS, Al-Sa'doni HH, Abdalla MY. Palladium-based chemotherapeutic agents: routes toward complexes with good antitumor activity. Cancer Therapy 2008; 6:1-10.
7. El-Sherif AA. Coordination chemistry of palladium(II) ternary complexes with relevant biomolecules. In: Innocenti A, editor. Stoichiometry and research - the importance of quantity in biomedicine. Manhattan, New York, USA: InTech; 2012. pp. 79-120.
8. Tercero-Moreno JM, Matilla-Hernandez A, Gonzalez-Garcia S, Niclos-Gutierrez J. Hydrolytic species of the ion cis-diaqua(ethylenediamine)- palladium(II) complex and of cis-dichloro(ethylenediamine)palladium(II): fitting its equilibrium models in aqueous media with or without chloride ion. Inorganica Chim Acta 1996; 253:23-29. (Pubitemid 126321363)
9. Rau T, Eldik Rv. In metal ions in biological systems. Platinum and other metal coordination compounds in cancer chemotherapy. New York, USA: Marcel Dekker; 1996.
10. Miklasova N, Fischer-Fodor E, Lonnecke P, Tomuleasa CI, Virag P, Schrepler MP, et al. Antiproliferative effect of novel platinum(II) and palladium(II) complexes on hepatic tumor stem cells in vitro. Eur J Med Chem 2012; 49:41-47.
11. Ulukaya E, Ari F, Dimas K, Ikitimur EI, Guney E, Yilmaz VT. Anti-cancer activity of a novel palladium(II) complex on human breast cancer cells in vitro and in vivo. Eur J Med Chem 2011; 46:4957-4963.
12. Ulukaya E, Ari F, Dimas K, Sarimahmut M, Guney E, Sakellaridis N, et al. Cell death-inducing effect of novel palladium(II) and platinum(II) complexes on non-small cell lung cancer cells in vitro. J Cancer Res Clin Oncol 2011; 137:1425-1434.
13. Ruiz J, Villa MD, Cutillas N, Lopez G, de Haro C, Bautista D, et al. Palladium(II) and platinum(II) organometallic complexes with 4,7-dihydro- 5-methyl-7-oxo[1,2,4]triazolo[1,5-a]pyrimidine. Antitumor activity of the platinum compounds. Inorg Chem 2008; 47:4490-4505.
14. Tusek-Bozic L, Furlani A, Scarcia V, De Clercq E, Balzarini J. Spectroscopic and biological properties of palladium(II) complexes of ethyl 2-quinolylmethylphosphonate. J Inorg Biochem 1998; 72:201-210. (Pubitemid 29101920)
15. Gao EJ, Wang L, Zhu MC, Liu L, Zhang WZ. Synthesis, characterization, interaction with DNA and cytotoxicity in vitro of the complexes [m(dmphen)(co3)].H2o [m=Pt(II), Pd(II)]. Eur J Med Chem 2010; 45:311-316.
16. Divsalar A, Saboury AA, Mansoori-Torshizi H, Ahmad F. Design, synthesis, and biological evaluation of a new palladium(II) complex: beta-lactoglobulin and k562 as targets. J Phys Chem B 2010; 114: 3639-3647.
17. Trevisan A, Marzano C, Cristofori P, Borella Venturini M, Giovagnini L, Fregona D. Synthesis of a palladium(II)-dithiocarbamate complex: biological assay and nephrotoxicity in rats. Arch Toxicol 2002; 76:262-268. (Pubitemid 34639521)
18. Acilan C, Serhatli M, Kacar O, Adiguzel Z, Tuncer A, Hayran M, et al. Smooth muscle cells isolated from thoracic aortic aneurysms exhibit increased genomic damage, but similar tendency for apoptosis. DNA Cell Biol 2012; 31:1523-1534.
19. Zhu N, Wang Z. An assay for DNA fragmentation in apoptosis without phenol/chloroform extraction and ethanol precipitation. Anal Biochem 1997; 246:155-158. (Pubitemid 27100523)
20. Guney E, Yilmaz VT, Sengul A, Buyukgungor O. Platinum(II) and palladium(II) saccharinato complexes with 2,2′ : 6′,2″- terpyridine: synthesis, characterization, crystal structures, photoluminescence and thermal studies. Inorg Chim Acta 2010; 363:438-448.
21. Cepeda V, Fuertes MA, Castilla J, Alonso C, Quevedo C, Perez JM. Biochemical mechanisms of cisplatin cytotoxicity. Anticancer Agents Med Chem 2007; 7:3-18. (Pubitemid 46062402)
22. Yin JL, Shackel NA, Zekry A, McGuinness PH, Richards C, Putten KV, et al. Real-time reverse transcriptase-polymerase chain reaction (RT-PCR) for measurement of cytokine and growth factor mRNA expression with fluorogenic probes or SYBR green I. Immunol Cell Biol 2001; 79:213-221. (Pubitemid 32522168)
23. Hsu SC, Yang JS, Kuo CL, Lo C, Lin JP, Hsia TC, et al. Novel quinolone chm-1 induces apoptosis and inhibits metastasis in a human osterogenic sarcoma cell line. J Orthop Res 2009; 27:1637-1644.
24. Kuo LJ, Yang LX. Gamma-h2ax - a novel biomarker for DNA double-strand breaks. In Vivo 2008; 22:305-309.
25. Roos WP, Kaina B. DNA damage-induced cell death by apoptosis. Trends Mol Med 2006; 12:440-450. (Pubitemid 44291571)
26. Li PF, Dietz R, von Harsdorf R. Differential effect of hydrogen peroxide and superoxide anion on apoptosis and proliferation of vascular smooth muscle cells. Circulation 1997; 96:3602-3609. (Pubitemid 27513439)
27. Llorente B, Smith CE, Symington LS. Break-induced replication: what is it and what is it for? Cell Cycle 2008; 7:859-864. (Pubitemid 351573777)
28. Basu A, Krishnamurthy S. Cellular responses to cisplatin-induced DNA damage. J Nucleic Acids 2010; 2010:1-16.
29. Frankenberg-Schwager M, Kirchermeier D, Greif G, Baer K, Becker M, Frankenberg D. Cisplatin-mediated DNA double-strand breaks in replicating but not in quiescent cells of the yeast Saccharomyces cerevisiae. Toxicology 2005; 212:175-184. (Pubitemid 40981974)
30. Icsel C, Yilmaz VT. DNA binding and cleavage studies of two palladium(II) saccharinate complexes with terpyridine. DNA Cell Biol 2013; 32:165-172.
31. Ulukaya E, Acilan C, Yilmaz Y. Apoptosis: why and how does it occur in biology? Cell Biochem Funct 2011; 29:468-480.
32. Enari M, Sakahira H, Yokoyama H, Okawa K, Iwamatsu A, Nagata S. A caspase-activated DNase that degrades DNA during apoptosis, and its inhibitor ICAD. Nature 1998; 391:43-50. (Pubitemid 28079208)
33. Sung YH, Lee JS, Park SH, Koo J, Lee GM. Influence of co-down-regulation of caspase-3 and caspase-7 by siRNAs on sodium butyrate-induced apoptotic cell death of Chinese hamster ovary cells producing thrombopoietin. Metab Eng 2007; 9:452-464. (Pubitemid 350016972)